Workflow
MRK Deadline Tomorrow: MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit
MRKMerck(MRK) Prnewswire·2025-04-13 17:38

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Merck & Co., Inc. securities between February 3, 2022, and February 3, 2025, of the April 14, 2025, lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 14, 2025 [2]. - The lawsuit claims that Merck provided misleading information regarding the expected revenue of 11billionfromGardasilsalesby2030whileconcealingadversefactsaboutdemandinChina[4].Group2:RosenLawFirm′sCredentials−RosenLawFirmhasastrongtrackrecordinsecuritiesclassactions,havingachievedthelargestsecuritiesclassactionsettlementagainstaChinesecompanyatthetime[3].−ThefirmwasrankedNo.1byISSSecuritiesClassActionServicesforthenumberofsettlementsin2017andhasrecoveredhundredsofmillionsforinvestors[3].−In2019,thefirmsecuredover11 billion from Gardasil sales by 2030 while concealing adverse facts about demand in China [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [3]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has recovered hundreds of millions for investors [3]. - In 2019, the firm secured over 438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3].